TCD SPIN OUT – SOLVOTRIN THERAPEUTICS SET TO COMMERCIALISE PATENTED ‘ACTIVEIRON’ TECHNOLOGY

Addresses Major Supplementation Barrier – Iron Intolerance Demonstrated Superior Bioavailability in Clinical Studies TCD spin-out and Enterprise Ireland High Performance ...